NDC properties for NDC 9 0121-0853
NDC item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | ACTIVE |
| NDA | NDA018615 |
NDC item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
NDC item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | COMPLETED |
NDC item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
NDC item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
NDC item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
NDC item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
NDC item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
NDC item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
NDC item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
NDC item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
NDC item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
NDC item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
NDC item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
NDC item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
NDC item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
NDC item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
NDC item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
NDC item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
NDC item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
NDC item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
NDC item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
NDC item 60687044224
| NDC 9 | 60687-442 |
|---|---|
| NDC 10 | 60687-442-24 |
| NDC Item | 60687044224 |
| packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 810430 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | ACTIVE |
NDC item 60687044253
| NDC 9 | 60687-442 |
|---|---|
| NDC 10 | 60687-442-53 |
| NDC Item | 60687044253 |
| packaging | 10 in 1 TRAY |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 810430 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | ACTIVE |
NDC item 60687044275
| NDC 9 | 60687-442 |
|---|---|
| NDC 10 | 60687-442-75 |
| NDC Item | 60687044275 |
| packaging | 4 TRAY in 1 CASE (60687-442-75) / 10 CUP, UNIT-DOSE in 1 TRAY (60687-442-53) / 20 mL in 1 CUP, UNIT-DOSE (60687-442-24) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 810430 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | ACTIVE |
NDC item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 846207 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
NDC item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 846207 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
NDC item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 846207 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
NDC item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
NDC item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
NDC item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 836867 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
NDC item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 836867 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
NDC item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 836867 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
NDC item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 839969 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
NDC item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
NDC item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
NDC item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
NDC item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
NDC item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
NDC item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
NDC item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
NDC item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-05-01 |
| Marketing status | ACTIVE |
NDC item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |